News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,049 Results
Type
Article (85225)
Company Profile (653)
Press Release (738171)
Section
Business (231692)
Career Advice (4093)
Deals (39625)
Drug Delivery (108)
Drug Development (90446)
Employer Resources (192)
FDA (17866)
Job Trends (17250)
News (394426)
Policy (39570)
Tag
Academia (2971)
Africa (1260)
Alliances (56311)
Alzheimer's disease (1252)
Approvals (17803)
Arizona (204)
Artificial intelligence (88)
Asia (48977)
Australia (8627)
Bankruptcy (393)
Best Places to Work (12268)
Biosimilars (73)
Biotechnology (453)
C2C Services and Suppliers (95111)
California (1988)
Canada (878)
Cancer (594)
Career advice (3500)
Cell therapy (168)
China (148)
Clinical research (70547)
Collaboration (185)
Compensation (96)
Connecticut (76)
COVID-19 (2756)
Cystic fibrosis (79)
Data (418)
Diabetes (78)
Diagnostics (6498)
Drug pricing (72)
Earnings (93223)
Employer resources (162)
Europe (112042)
Events (124961)
Executive appointments (160)
FDA (18094)
Florida (235)
Funding (169)
Gene therapy (118)
GLP-1 (598)
Government (5007)
Healthcare (20592)
Hotbed/Location (534575)
Illinois (289)
Indiana (149)
Infectious disease (2788)
Inflammatory bowel disease (104)
Interviews (805)
IPO (17472)
Job creations (5174)
Job search strategy (2850)
Kansas (100)
Layoffs (471)
Legal (10003)
Lung cancer (118)
Manufacturing (115)
Maryland (452)
Massachusetts (1765)
Medical device (14200)
Medtech (14205)
Mergers & acquisitions (21956)
Metabolic disorders (278)
Michigan (124)
Minnesota (216)
Neuroscience (1434)
New Jersey (609)
New York (606)
NextGen Class of 2024 (7624)
Non-profit (5043)
North Carolina (702)
Northern California (833)
Obesity (163)
Ohio (101)
Opinion (235)
Patents (77)
Pennsylvania (551)
People (63721)
Pharmaceutical (127)
Phase I (21680)
Phase II (30625)
Phase III (23144)
Pipeline (124)
Podcasts (79)
Postmarket research (3532)
Preclinical (9784)
Radiopharmaceuticals (237)
Rare diseases (148)
Real estate (7362)
Recruiting (72)
Regulatory (25603)
Research institute (2634)
Resumes & cover letters (646)
South America (1645)
Southern California (785)
Startups (4271)
Texas (239)
United States (9064)
Vaccines (565)
Washington State (277)
Weight loss (152)
Date
Last 7 days (557)
Last 30 days (2116)
Last 365 days (37364)
2024 (27714)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
824,049 Results for "rejuvenate bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rejuvenate Bio Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM)
Funding will advance development of Rejuvenate’s one-time gene therapy RJB-0402 for the treatment of desmoplakin gene variant arrhythmogenic cardiomyopathy
July 1, 2024
·
4 min read
Biotech Beach
Rejuvenate Bio to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Rejuvenate Bio today announced an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting, taking place May 7 – 11, 2024, in Baltimore, MD and virtually.
April 22, 2024
·
2 min read
Biotech Beach
Rejuvenate Bio Announces Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in the Journal Cellular Reprogramming
Rejuvenate Bio today announced publication of groundbreaking research in the peer-reviewed journal Cellular Reprogramming.
February 22, 2024
·
3 min read
Biotech Beach
Rejuvenate Bio Announces Partnership with Leading Animal Health Company to Develop Gene Therapy for Canine Osteoarthritis
Rejuvenate Bio today announced a partnership with a leading animal health company for the development and commercialization of its novel gene therapy technology for the treatment of canine osteoarthritis (OA), a complex chronic disease that affects dogs’ mobility and overall quality of life.
February 14, 2024
·
2 min read
Press Releases
ImmuneAGE Bio launches to rejuvenate the immune system targeting bone marrow stem cells
July 12, 2024
·
2 min read
Drug Development
Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402 for the Treatment of Arrhythmogenic Cardiomyopathy
Rejuvenate Bio, today announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key disease-mediating pathways.
October 9, 2023
·
4 min read
INmune Bio Inc. to Deliver Keynote Talk at 5th World Aging and Rejuvenation Conference.
INmune Bio, Inc. has been invited to discuss drug development strategies in aging and rejuvenation at the 5th World Aging and Rejuvenation Conference in Frankfurt, Germany on July 17, 2023.
July 12, 2023
·
6 min read
Press Releases
Rejuvenate Biomed and SAS tap AI to develop disease-agnostic drug repurposing discovery tools
August 1, 2024
·
3 min read
Layoffs
Bluebird Bio to Lay Off 25% of Workforce
About a month after reporting it’s had a tough time starting enough patients on its treatments, bluebird bio announced it will lay off about 25% of its employees, over half of whom work in R&D.
September 24, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Mercury Bio Appoints Biotech Innovator Alex Koglin, Ph.D. to Board of Directors
With the addition of NTx’s co-founder and former President to the board Mercury Bio significantly enhances its strategic reach in the biotech sector
October 1, 2024
·
2 min read
1 of 82,405
Next
